PAREXEL Announces New Patient-Centric Innovations to Address Drug Development Challenges


Applied Clinical Trials

PAREXEL International Corporation, a provider of global biopharmaceutical services, announced that it has developed new solutions that take a patient-centric approach to addressing drug development. These solutions were built on the Perceptive Cloud platform in hopes to leverage mobile and wearable technology.

Read the full release here.  

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.